Colgate-Palmolive (CL) Shares Sold by Flagship Harbor Advisors LLC

Flagship Harbor Advisors LLC cut its stake in Colgate-Palmolive (NYSE:CL) by 9.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,286 shares of the company’s stock after selling 1,630 shares during the quarter. Flagship Harbor Advisors LLC’s holdings in Colgate-Palmolive were worth $1,104,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Transamerica Financial Advisors Inc. grew its position in Colgate-Palmolive by 0.3% during the first quarter. Transamerica Financial Advisors Inc. now owns 25,183 shares of the company’s stock valued at $1,844,000 after buying an additional 67 shares during the period. Ronald Blue & Co. LLC grew its position in Colgate-Palmolive by 1.1% during the first quarter. Ronald Blue & Co. LLC now owns 3,501 shares of the company’s stock valued at $256,000 after buying an additional 37 shares during the period. USS Investment Management Ltd grew its position in Colgate-Palmolive by 1.6% during the first quarter. USS Investment Management Ltd now owns 683,600 shares of the company’s stock valued at $50,036,000 after buying an additional 10,600 shares during the period. Stifel Financial Corp grew its position in Colgate-Palmolive by 0.8% during the first quarter. Stifel Financial Corp now owns 303,934 shares of the company’s stock valued at $22,250,000 after buying an additional 2,360 shares during the period. Finally, ARS Investment Partners LLC grew its position in Colgate-Palmolive by 0.5% during the first quarter. ARS Investment Partners LLC now owns 35,531 shares of the company’s stock valued at $2,601,000 after buying an additional 175 shares during the period. Hedge funds and other institutional investors own 72.96% of the company’s stock.

In other news, insider Victoria L. Dolan sold 9,000 shares of the business’s stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total value of $660,690.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Stephen I. Sadove sold 20,780 shares of the business’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the completion of the transaction, the director now directly owns 36,268 shares in the company, valued at approximately $2,557,619.36. The disclosure for this sale can be found here. Insiders sold 181,048 shares of company stock worth $13,168,995 in the last three months. Insiders own 1.02% of the company’s stock.

Colgate-Palmolive (NYSE CL) opened at $74.05 on Monday. The firm has a market cap of $65,023.68, a P/E ratio of 25.80, a price-to-earnings-growth ratio of 3.39 and a beta of 0.81. Colgate-Palmolive has a 12-month low of $63.43 and a 12-month high of $77.27. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business had revenue of $3.97 billion during the quarter, compared to analyst estimates of $3.94 billion. During the same period in the prior year, the business posted $0.73 earnings per share. The company’s revenue was up 2.8% on a year-over-year basis. sell-side analysts anticipate that Colgate-Palmolive will post 2.88 EPS for the current year.

Several brokerages recently issued reports on CL. Deutsche Bank began coverage on shares of Colgate-Palmolive in a research report on Wednesday, December 13th. They set a “hold” rating and a $75.00 target price for the company. Societe Generale lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 target price for the company. in a research report on Wednesday, November 29th. They noted that the move was a valuation call. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Wednesday, November 8th. Finally, Citigroup cut their target price on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a research report on Thursday, November 2nd. Two equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $76.04.

TRADEMARK VIOLATION NOTICE: “Colgate-Palmolive (CL) Shares Sold by Flagship Harbor Advisors LLC” was originally published by Markets Daily and is the property of of Markets Daily. If you are viewing this story on another publication, it was copied illegally and republished in violation of US & international trademark and copyright legislation. The original version of this story can be viewed at https://www.themarketsdaily.com/2017/12/18/colgate-palmolive-cl-shares-sold-by-flagship-harbor-advisors-llc.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply